3 ms·
I am wondering if this other results are related, of the article Autoantibodies against ACE2 and angiotensin type-1 receptors increase severity of COVID-19 ht
by mdp2021 5y ago
I am wondering if this other results are related, of the article
Autoantibodies against ACE2 and angiotensin type-1 receptors increase severity of COVID-19
https://www.sciencedirect.com/science/article/pii/S0896841121000913 https://www.sciencedirect.com/science/article/pii/S089684112...
(Journal of Autoimmunity)
or, COVID19 is worse when an autoimmune response against ACE2 occurs, and the same autoimmune response is at the root of "long COVID".
> Severity of several inflammation-related diseases has been associated with autoantibodies against RAS [renin-angiotensin system], particularly agonistic autoantibodies for angiotensin type-1 receptors (AA-AT1) and autoantibodies against ACE2 (AA-ACE2). ... The present results suggest that both AA-AT1 and AA-ACE2 contribute to increase in severity of COVID-19 outcome and could be used as an index of probable progression of COVID-19 towards severity. ... the results encourage further studies on the possible protective treatment with AT1 receptor blockers in COVID-19